Neuroprotective effects of kynurenine-3-hydroxylase inhibitors in models of brain ischemia

Advances in Experimental Medicine and Biology

Volumn 467, Issue , 2000, Pages 199-206

  Moroni, F ^a   Cozzi, A ^a   Peruginelli, F ^a   Carpenedo, R ^a   Pellegrini Giampietro, D E ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROBENZOYLALANINE; 3,4 DIMETHOXY N [4 (3 NITROPHENYL) 2 THIAZOLYL]BENZENESULFONAMIDE; 3,4 DIMETHOXY[N 4 (NITROPHENYL)THIAZOL 2 YL]BENZENESULFONAMIDE; ENZYME INHIBITOR; GLUCOSE; KYNURENINE 3 MONOOXYGENASE; OXYGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN ISCHEMIA; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; GERBIL; HIPPOCAMPUS; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL LESION; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT;

ALANINE; ANIMALS; BRAIN ISCHEMIA; CEREBRAL INFARCTION; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; GERBILLINAE; HIPPOCAMPUS; ISCHEMIC ATTACK, TRANSIENT; KYNURENINE 3-MONOOXYGENASE; MIXED FUNCTION OXYGENASES; NEUROPROTECTIVE AGENTS; PYRAMIDAL CELLS; RATS; RATS, WISTAR; SULFONAMIDES; THIAZOLES;

ANIMALIA; GERBILLINAE;

EID: 0034466539     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (38)

1. Mechanisms and effects of intracellular calcium buffering on neuronal survival in organotypic hippocampal cultures exposed to anoxia/aglycemia or to excitotoxins
2. Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenic acid and have sedative and anticonvulsant activities
3. A study of the dose dependency of a glycine receptor antagonist in focal ischemia
4. Comparison of the neurochemical and behavioral effects resulting from the inhibition of kynurenine hydroxylase and/or kynureninase
5. Glutamate neurotoxicity and diseases of the nervous system
6. The free radical trapping agent N-tert-butyl-a-phenylnitrone (PBN) attenuates cerebral ischaemic injury in gerbils
7. Nicotinylalanine increases cerebral kynurenic acid content and has anticonvulsant activity
8. Effects of central administration of kynurenic acid on spontaneous locomotor activity in kindled rat: A multivariate approach of using the automated Digiscan monitoring system
9. Citotoxicity of 3-hydroxykynurenine in a neuronal hybrid cell line
10. Systemic administration of MK-801 protects against ischemia-induced hippocampal neuronal degeneration in the gerbil
11. Oxygen radicals and the nervous system
12. Metal-mediated oxidative damage to cellular and isolated DNA by certain tryptophan metabolites
13. A glycine site associated with NMDA receptors: Characterisation and identification of a new class of antagonist
14. Delayed neuronal death in the gerbil hippocampus following ischemia
15. Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters
16. Presence of kynurenic acid in the mammalian brain
17. Modulation of quinolinic and kynurenic acid content in the rat brain: Effects of endotoxins and nicotinylalanine
18. Thiokynurenates prevent excitotoxic neuronal death in vitro and in vivo by acting as glycine antagonists and as inhibitors of lipid peroxidation
19. 3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity
20. Excitotoxic amino acids and neuropsychiatric disorders
21. Pathological changes induced in cerebrocortical neurons in phencyclidine related drugs
22. Excitatory amino acid release from rat hippocampal slices as a consequence of free radical formation
23. Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage
24. The glycine antagonist and free radical scavenger 7-C1-thio-kynurenate reduces CA1 ischemic damage in the gerbil
25. Modulation of the kynurenine pathway in search for new neuroprotective agents. Synthesis and preliminary evaluation of (m-nitrobenzoyl)alanine, a potent inhibitor of kynurenine-3-hydroxylase
26. Protection from cerebral ischemic injury in gerbils with the spin trap agent N-tert-butyl-a-phenylnitrone (PBN)
27. Selective N-type calcium channel antagonist omega conotoxin MVIIA is neuroprotective against hypoxic neurodegeneration in organotypic hippocampal-slice cultures
28. Synthesis and biochemical evaluation of N-(4-phenylthiazol-yl)benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase
29. The NMDA receptor, NMDA antagonists and epilepsy therapy
30. Nicotinylalanine increases the formation of kynurenic acid in the brain and antagonizes convulsions
31. Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain
32. Modulation of seizure susceptibility in the mouse by the strychnine-insensitive glycine recognition site of the NMDA receptor/ion channel complex
33. NMDA antagonists: Their role in neuroprotection
34. (R,S)-3.4-dichlorobenzoylalanine (FCE 28833A) causes a large and persistent increase in brain kynurenic acid levels in rats
35. Neuropharmacology of quinolinic and kynurenic acids
36. A simple method for organotypic cultures of nervous tissue
37. Focal cerebral ischemia in rats: Description of the technique and early neuropathological consequences following middle cerebral artery occlusion
38. Different stereoselectivity of the enantiomers of HA-966 (3-amino-l-hydroxy-2-pyrrolidinone) for neuroprotective and anticonvulsant actions in vivo